Sanofi’s Fluzone quadrivalent formulation gets FDA nod in older people

Sanofi secures FDA approval for Fluzone High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older. Photo: courtesy of Sanofi.